

1,402,106 filings since 2004 · latest accepted Nov 4, 2026, 10:45 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 22, 2025 accepted 8:39 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jul 21, 2025 accepted 1:27 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreementOfficer / director change |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Mar 17, 2025 accepted 9:19 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Feb 27, 2023 accepted 11:48 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Sep 1, 2022 accepted 8:31 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 2, 2022 accepted 10:24 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Aug 26, 2021 accepted 11:16 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Aug 13, 2021 accepted 11:05 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Jul 2, 2021 accepted 9:05 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement1.02Agreement terminated8.01Other events | DocumentSEC ↗ |
Feb 16, 2021 accepted 11:21 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.02Earnings release8.01Other events | DocumentSEC ↗ |
Oct 1, 2020 accepted 9:21 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jun 8, 2020 accepted 9:04 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change5.07Shareholder vote | DocumentSEC ↗ |
Mar 12, 2020 accepted 12:04 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Jul 29, 2019 accepted 11:09 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
May 21, 2019 accepted 11:35 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Jul 24, 2018 accepted 8:05 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Dec 1, 2017 accepted 9:06 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Oct 19, 2017 accepted 8:07 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jul 25, 2017 accepted 8:59 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Dec 7, 2016 accepted 10:26 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Oct 13, 2015 accepted 9:29 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.02Earnings release3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Sep 29, 2014 accepted 8:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Sep 18, 2013 accepted 9:22 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Jun 19, 2013 accepted 10:02 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Feb 16, 2012 accepted 10:06 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Mar 18, 2011 accepted 10:02 AM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Sep 7, 2010 accepted 5:27 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Dec 22, 2009 accepted 9:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Dec 1, 2009 accepted 12:29 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jan 17, 2008 accepted 9:15 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Oct 25, 2007 accepted 9:25 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Aug 10, 2007 accepted 7:29 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Aug 6, 2007 accepted 8:45 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jun 4, 2007 accepted 8:49 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Mar 2, 2007 accepted 7:39 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Jan 8, 2007 accepted 7:45 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.01Change in control5.02Officer / director change5.06Shell status change | DocumentSEC ↗ |
Aug 24, 2006 accepted 6:44 PM ET | PLXProtalix BioTherapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |